BeOne Medicines AG (ONC) Investment Research Dashboard
About BeOne Medicines AG (ONC) stock analysis
Get live ONC stock price $330.46, comprehensive BeOne Medicines AG stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ONC stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule...
Company Information
- CEO
- John V. Oyler
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 12000
Contact Information
- Website
- https://beonemedicines.com
- Address
- 94 Aeschengraben 27
- Country
- CH
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Listed on major US exchange (NASDAQ) providing liquidity and transparency
✓ Growth-oriented company with premium valuation (P/E: 73.9)
✓ Lower volatility stock (Beta: 0.49) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for BeOne Medicines AG shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for BeOne Medicines AG
- ⚠Investors should consider how BeOne Medicines AG fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 73.9) requires strong growth to justify
Market Cap
35.31B
P/E Ratio (TTM)
73.93
Beta
0.49
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ONC with peer companies:
- Price
- $140.56+1.93% (1D)
- Market cap
- 39.70B
- Price
- $69.12+2.73% (1D)
- Market cap
- 33.71B
- Price
- $64.11+4.89% (1D)
- Market cap
- 29.16B
- Price
- $388.89+2.03% (1D)
- Market cap
- 46.69B
- Price
- $104.13-0.57% (1D)
- Market cap
- 22.57B
- Price
- $243.16+14.04% (1D)
- Market cap
- 40.58B
- Price
- $1,388.53+3.91% (1D)
- Market cap
- 28.06B
- Price
- $252.22-2.25% (1D)
- Market cap
- 36.12B
- Price
- $25.55+2.10% (1D)
- Market cap
- 24.81B
- Price
- $208.99+2.91% (1D)
- Market cap
- 30.31B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
73/100 ⭐⭐⭐⭐⭐
- Overall
- +0.6%
- NYSE
- +0.7%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +1.9% | +2.8% | +4.0% | 19.2 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.5% | -0.5% | +3.1% | 22.3 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.6% | +1.2% | +1.5% | 24.0 | 73/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +1.7% | +0.2% | 25.3 | 66/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.0% | +2.0% | +0.9% | 29.8 | 63/100⭐⭐⭐⭐ |
| Real Estate | +0.4% | +0.9% | -1.6% | 29.5 | 50/100⭐⭐⭐ |
| Energy | -1.7% | -3.3% | -3.7% | 19.2 | 39/100⭐⭐ |
| Utilities | -1.1% | -0.0% | -4.5% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.7% | +0.5% | -9.8% | 30.0 | 21/100⭐ |
| Technology | +0.9% | -1.3% | -6.9% | 40.9 | 18/100⭐ |
| Consumer Cyclical | +0.3% | -1.7% | -6.0% | 42.8 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.